News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Combination immunotherapy treatment with anti-PD-1 and anti-CTLA-4 checkpoint inhibitors has proven effective as a front-line option for many patients…
Merkel cell carcinoma (MCC) is a rare and aggressive form of skin cancer caused by…
Most head and neck cancer patients treated with radiation therapy develop long-term treatment-related dry mouth, or xerostomia,…
Cancer-related fatigue (CRF) is the most common symptom in patients with cancer, and there are limited…
To be presented at the American Society of Clinical Oncology’s (ASCO) Annual Meeting, 03 – 07 June…
The first of a planned 100 patients has been enrolled on a new cancer trial…
Australia is facing a looming skills shortage to deal with a predicted 50 per cent…
Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder…
Friday, May 20 is International Clinical Trials Day, a day that highlights the importance of…
Friday, May 20 is International Clinical Trials Day, a day that highlights the importance of…